Androgen receptors in benign and malignant prostatic tissue
- PMID: 94714
Androgen receptors in benign and malignant prostatic tissue
Abstract
A new procedure has been developed to purify prostatic cell nuclei and to achieve a high yield of nuclear material for study. This technique allowed the investigation of the enzyme 5-alpha-reductase and its relationship to the translocation of dihydrotestosterone and androgen receptors into the nucleus of the prostatic cell. The studies revealed that 5-alpha-reductase was localized chiefly to the stromal components of all types of prostatic tissue. Although there is a higher concentration of dihydrotestosterone in carcinoma tissue the 5-alpha-reductase activity is low. Studies on the effect of androgens and antiandrogens on nuclear uptake of androgen revealed that androgens are potent stimulants of receptor translocation, while antiandrogens stimulate little or no translocation.
Similar articles
-
Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency.Cancer Res. 1978 Nov;38(11 Pt 2):4349-52. Cancer Res. 1978. PMID: 81107
-
Protamine sulfate precipitation of androgen receptors in cytosols of human benign and malignant prostatic tumors.Prog Clin Biol Res. 1979;33:13-32. Prog Clin Biol Res. 1979. PMID: 93749 No abstract available.
-
The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.Clin Cancer Res. 2004 Nov 1;10(21):7121-6. doi: 10.1158/1078-0432.CCR-04-0913. Clin Cancer Res. 2004. PMID: 15534082
-
Androgen receptor assays in advanced prostatic cancer.Urol Clin North Am. 1984 May;11(2):311-7. Urol Clin North Am. 1984. PMID: 6375068 Review.
-
Androgen receptors and the molecular basis for the action of antiadrogens in the ventral prostate.J Reprod Fertil Suppl. 1976 Sep;(24 suppl):147-62. J Reprod Fertil Suppl. 1976. PMID: 794465 Review.